Fisher BioServices

Core Business and Operations

The primary function of Fisher BioServices is to act as a world leader in biological specimen management. This encompasses the entire life cycle of a biological sample, from collection and processing to long-term archival and distribution. The company operates a global network of over 20 state-of-the-art biorepository facilities and manages an immense inventory, storing and distributing hundreds of millions of biological specimens. The operations are grounded in strict adherence to industry best practices, including those set by the International Society of Biological and Environmental Repositories (ISBER), the National Cancer Institute (NCI), and the Parenteral Drug Association (PDA).

The company's core activities can be segmented into two major areas: Biorepository and Biobanking Services and Specialized Logistics and Clinical Supply Chain Management.

Products and Services Offered

Fisher BioServices offers a comprehensive suite of services, often delivered as integrated, turn-key solutions, to support complex research and therapeutic development programs:

1. Biorepository and Biobanking

This service forms the foundation of the company's offering, providing secure, compliant, and monitored long-term storage for critical biological materials. * Sample Storage: Management of a wide range of materials, including biological specimens, cell-based therapeutics, vaccines, tissues, and Biologic Active Pharmaceutical Ingredients (API). Storage configurations are developed for a multitude of biologics, ensuring proper environmental control for high-value material. * Integrated Sample Processing and Laboratory Services: Facilities for sample processing are located within the biorepositories to offer integrated sample management. These services include sample preparation, DNA/RNA extraction, and molecular testing services such as Polymerase Chain Reaction (PCR) and quantitative Real-Time PCR (qPCR), including Whole Genome Amplification (WGA PCR). * Turn-Key Biobanking Solutions: Providing full-service solutions that span biospecimen collection, processing, testing, storage, and sample and data management.

2. Specialized Cold Chain Logistics and Distribution

Fisher BioServices is a leading provider of ultra cold chain logistics, which is crucial for maintaining the viability and efficacy of temperature-sensitive biologics. * Ultra Cold Chain Transportation: Expertise in moving high-value biologics and cryogenically frozen cell-based therapeutics at ultra-low temperatures, often utilizing cryogenic shipping containers. * Clinical and Commercial Logistics: Specialized support for transporting materials from the manufacturer to the patient bedside for both clinical trials and commercial supply, managing the unique logistical and regulatory challenges of moving sensitive products globally. * Chain of Custody Solutions: Providing customized, end-to-end chain of custody solutions for pharmaceutical clients and partners, ensuring integrity and traceability of valued material.

3. Clinical Trial and Research Support

The company integrates its biorepository and logistics expertise to support clinical and translational research. * Clinical Trial Sample Management: Comprehensive services to manage samples collected during clinical studies, ensuring proper documentation, storage, and retrieval for analysis. * Clinical Trial Supply Services: Services that encompass the complex logistics and inventory management required for clinical assets. * Data and Inventory Management: Utilization of specialized software, such as Thermo Scientific Nautilus biospecimen tracking software, and robust Laboratory Information Management Systems (LIMS) to ensure accurate, timely cataloging, archiving, and retrieval of samples and associated data. This is essential for efficient cataloging and archiving in translational medicine.

By offering a robust portfolio of services centered on the secure and compliant management of biological materials, Fisher BioServices is positioned as an industry leader supporting the advancement of cell therapy, high-value biologics, and large-scale public health research.